Kimia Biosciences (BOM:530313) LT-Debt-to-Total-Asset: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530313 Kimia Biosciences Ltd BOM:530313
23 GF Score
Price ₹28.79
View Full Analysis

What is Kimia Biosciences LT-Debt-to-Total-Asset?

Kimia Biosciences BOM:530313 +5.57% 23 LT-Debt-to-Total-Asset is 0.00 as of . 20. GuruFocus rates BOM:530313 with a GF Score™ of 23/100.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Kimia Biosciences's long-term debt to total assests ratio for the quarter that ended in . 20 was 0.00.

Kimia Biosciences's long-term debt to total assets ratio stayed the same from . 20 (0.00) to . 20 (0.00).

Kimia Biosciences  (BOM:530313) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Kimia Biosciences LT-Debt-to-Total-Asset Related Terms

Kimia Biosciences LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Kimia Biosciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences LT-Debt-to-Total-Asset Chart

Kimia Biosciences Annual Data
Trend
LT-Debt-to-Total-Asset

Kimia Biosciences Semi-Annual Data
LT-Debt-to-Total-Asset
BOM:530313
23GF Score
Kimia Biosciences Ltd BOM:530313
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kimia Biosciences LT-Debt-to-Total-Asset Calculation

Kimia Biosciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in . 20 is calculated as

LT Debt to Total Assets (A: . 20 )=Long-Term Debt & Capital Lease Obligation (A: . 20 )/Total Assets (A: . 20 )
=/
=

Kimia Biosciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in . 20 is calculated as

LT Debt to Total Assets (Q: . 20 )=Long-Term Debt & Capital Lease Obligation (Q: . 20 )/Total Assets (Q: . 20 )
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Kimia Biosciences (BOM:530313) has a LT-Debt-to-Total-Asset of 0.00 as of . 20. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Kimia Biosciences and its competitors.
Is Kimia Biosciences' LT-Debt-to-Total-Asset too high?
Kimia Biosciences' current LT-Debt-to-Total-Asset is 0.00. Overall, Kimia Biosciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Kimia Biosciences' LT-Debt-to-Total-Asset compare to ZTS?
Kimia Biosciences' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Kimia Biosciences and its competitors. Kimia Biosciences's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kimia Biosciences stock overvalued right now?
Kimia Biosciences (BOM:530313) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Kimia Biosciences' overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Kimia Biosciences (BOM:530313), the current LT-Debt-to-Total-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kimia Biosciences Business Description

Address Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Prucalopride, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.
23GF Score

Get the complete analysis for BOM:530313

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹28.79
Price